Bottom line
LHCAX vs PHSYX: the short answer
LHCAX (Lord Abbett Health Care Fund) and PHSYX (Putnam Global Health Care Fund) are both mutual funds.
PHSYX is cheaper at 0.79% vs 1.03% — a difference of $24 a year per $10,000 invested.
Over five years, PHSYX returned +8.1% a year vs +3.1% for LHCAX (reporting dates differ).
LHCAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
LHCAX vs PHSYX side by side
| LHCAX | PHSYX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Lord Abbett | Franklin Templeton |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.03% | 0.79% |
| Annual cost per $10k | $103 | $79 |
| 10-yr cost on $10k (prospectus) | $3,961 | $978 |
| Max front load | 5.75% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +10.9% | +1.5% |
| 5-yr return (annualized) | +3.1% | +8.1% |
| 10-yr return (annualized) | — | +7.8% |
| Best quarter | +21.5% | — |
| Worst quarter | −11.4% | — |
| Net assets (fund) | $8.6M | $1.5B |
| Number of holdings | 61 | 115 |
| Portfolio turnover | 91% | 67% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of LHCAX's top 25 holdings also appear in PHSYX's top 25.
| Holding | LHCAX | PHSYX |
|---|---|---|
| Eli Lilly & Co | 10.40% | 13.15% |
| UnitedHealth Group Inc | 5.39% | 6.93% |
| Johnson & Johnson | 4.96% | 8.46% |
| Novartis AG | 4.19% | 5.13% |
| Gilead Sciences Inc | 3.53% | 2.63% |
| CVS Health Corp | 3.33% | 2.74% |
| Thermo Fisher Scientific Inc | 2.31% | 4.50% |
| Vertex Pharmaceuticals Inc | 2.24% | 1.97% |
| AstraZeneca PLC | 1.97% | 4.67% |
| Edwards Lifesciences Corp | 1.78% | 2.80% |
Source: SEC Form N-PORT
LHCAX top 10
- Eli Lilly & Co — 10.40%
- UnitedHealth Group Inc — 5.39%
- Johnson & Johnson — 4.96%
- Novartis AG — 4.19%
- Natera Inc — 3.60%
- Gilead Sciences Inc — 3.53%
- CVS Health Corp — 3.33%
- Guardant Health Inc — 2.61%
- Galderma Group AG — 2.60%
- Thermo Fisher Scientific Inc — 2.31%
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
FAQ
What is the difference between LHCAX and PHSYX?
Which is cheaper, LHCAX or PHSYX?
Should I own both LHCAX and PHSYX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.